Cargando...
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma
Glioblastoma (GBM) is a challenging diagnosis with almost universally poor prognosis. Though the survival advantage of postoperative radiation (RT) is well established, around 90% of patients will fail in the RT field. The high likelihood of local failure suggests the efficacy of RT needs to be impr...
Guardado en:
| Publicado en: | Neurooncol Pract |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7274183/ https://ncbi.nlm.nih.gov/pubmed/32537176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz057 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|